Clinical Trial Update: Efficacy of Flavocoxid 500 mg Compared With Naproxen 500 mg in Subjects With Moderate-severe Osteoarthritis of the Knee [NA]

View source ↗

Summary

A completed clinical trial comparing flavocoxid 500 mg with naproxen 500 mg for moderate-severe knee osteoarthritis; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis of the Knee

Drugs mentioned

• Flavocoxid 500 mg (flavocoxid)
• Naproxen 500 mg (naproxen)

Snippet

Sponsor: Primus Pharmaceuticals | Conditions: Osteoarthritis of Knee | NA | Status: COMPLETED | Results posted: 2022-11-01